Genprex (GNPX)

Healthcare · Biotechnology

1 member of Congress has disclosed 4 trades in Genprex (GNPX) since 2025: 4 buys and 0 sales. The most recent was disclosed on Feb 20, 2026.

Trades disclosed: 4
Members trading: 1
Buys / sells: 4 / 0
Reported value: $18K–$95K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow GNPX

What else is happening at GNPX

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.

Who traded GNPX

MemberBuysSalesLast disclosed

Rep. Tim Moore (R-NC-14)4 buys · 0 sales40Feb 20, 2026

All trades

DisclosedTradeAmount

Feb 20, 2026
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$1K–$15K · Traded Feb 5, 2026 · disclosed Feb 20, 2026
$1K–$15K
Jan 7, 2026
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 7, 2026
$1K–$15K
Dec 2, 2025
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$1K–$15K · Traded Nov 7, 2025 · disclosed Dec 2, 2025
$1K–$15K
Nov 12, 2025
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$15K–$50K · Traded Oct 29, 2025 · disclosed Nov 12, 2025
$15K–$50K

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.